Pompano Beach, May 11, 2015 (GLOBE NEWSWIRE) -- -- DS Healthcare Group, Inc. (NASDAQ:DSKX), today announced it will soon begin selling to Farmacias Benavides, Mexico’s third largest pharmacy chain recently acquired by Alliance Boots GmbH, the European pharmacy retailer and wholesaler owned in part by Walgreens Co. (NASDAQ: WBA)
“We are thrilled to enter into this relationship with Benavides as we continue to expand our distribution into Mexico. The Mexican market represents the company’s largest percentage of revenue outside the US and is our fastest growing demographic. We believe that this new sales channel within our Mexican distribution will play an important role in our continued success in the region and will further solidify the existing presence we have there”, said Daniel Khesin, president and CEO of DS Healthcare Group. “We are extremely confident that this new relationship will yield strong financial benefits to our company as we continue to drive sales and profits in our Mexican market ”, Khesin concluded.
Fernando Tamez, M.D., CEO of DS Laboratories S.A., a wholly owned subsidiary in Mexico of DS Healthcare Group added, “our new business relationship with Farmacias Benavidas is further confirmation of our company’s ability to provide customers with even greater access to our products and we are now becoming a household name in Mexico. The timing could not be better as it coincides with the launch of our Ingera hair regrowth tablet.
About DS Healthcare Group
DS Healthcare Group Inc. leads in the development of biotechnology for topical therapies. It markets through online and specialty retailers, distributors, cosmetics wholesalers, and salons. Its research has led to a highly innovative portfolio of personal care products and additional innovations in pharmaceutical projects. For more information on DS Health Group's flagship brand, visit www.dslaboratories.com
Walgreens (www.walgreens.com), the nation's largest drugstore chain, constitutes the Retail Pharmacy USA Division of Walgreens Boots Alliance, Inc. (Nasdaq: WBA), the first global pharmacy-led, health and wellbeing enterprise. More than 8 million customers interact with Walgreens each day in communities across America, using the most convenient, multichannel access to consumer goods and services and trusted, cost-effective pharmacy, health and wellness services and advice. Walgreens operates 8,232 drugstores with a presence in all 50 states, the District of Columbia, Puerto Rico and the U.S. Virgin Islands. Walgreens digital business includes Walgreens.com, drugstore.com, Beauty.com, SkinStore.com and VisionDirect.com. Walgreens also manages more than 400 Healthcare Clinic and provider practice locations around the country.
Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies, and are generally preceded by words such as "future," "plan" or "planned," "expects, "or "projected." These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing and marketing products, intense competition, and additional risks factors as discussed in reports filed by the company with the Securities and Exchange Commission, which are available at http://www.sec.gov.
Contact: Abner Silva DS Healthcare Group, Inc. 407.342.4112 Abner@DSHealthgroup.com
Source:DS Healthcare Group, Inc.